SPONSOR
Peking University
Total Trials
4
Recruiting
4
Phases
Phase 1, EARLY_Phase 1
Conditions studied: Advanced or Recurrent Solid TumorsAdvanced Malignant Solid Tumor of Digestive SystemBiliary Tract Cancer (BTC)Advanced Solid Tumor Cancer
Peking University is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Advanced or Recurrent Solid Tumors, Advanced Malignant Solid Tumor of Digestive System, Biliary Tract Cancer (BTC), Advanced Solid Tumor Cancer.
The trial portfolio spans Phase 1, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Peking University
How many clinical trials has Peking University sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Peking University, of which 4 are actively recruiting participants. These trials cover conditions including Advanced or Recurrent Solid Tumors, Advanced Malignant Solid Tumor of Digestive System, Biliary Tract Cancer (BTC). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Peking University research focus on?
Peking University clinical trials span Advanced or Recurrent Solid Tumors, Advanced Malignant Solid Tumor of Digestive System, Biliary Tract Cancer (BTC), Advanced Solid Tumor Cancer. The research pipeline includes Phase 1, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Peking University clinical trial?
To participate in a Peking University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Peking University trials with current recruitment status updated daily.
Clinical Trials by Peking University
NCT06541639 Phase 1
Recruiting
EVM16 Injection As a Single and Combination with Tislelizumab in Solid Tumors
Advanced or Recurrent Solid Tumors
NCT06380309 EARLY_Phase 1
Recruiting
A Clinical Study on Evaluating Intravenous Administration of IDOV-SAFE
Advanced Malignant Solid Tumor of Digestive System
NCT07466238
Recruiting
HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer
Biliary Tract Cancer (BTC)
NCT07139067 Phase 1
Recruiting
Phase I Clinical Study of YK1101 Injection for the Treatment of Advanced Solid Tumors
Advanced Solid Tumor Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology